Fig. 1From: Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort studyOverall survival of patients with LAPA who received FOLFIRINOX or gemcitabine as induction chemotherapy: a overall survival of all patients, and b overall survival of patients aged ≤75 years and performance status (PS) score of 0–1. LAPA, locally advanced pancreatic adenocarcinomaBack to article page